Get the app
NSEHealthcare

Panacea Biotec Limited (PANACEABIO)

NSE · Healthcare · Biotechnology

₹372.00+1.32%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
₹200 cr
Revenue YoY
+19.7%
Net profit
₹2 cr
Profit YoY
-43.2%
EPS
₹-5.49
EPS estimate
₹1.80
Net margin
1.2%

EPS came in at -5.49 against a street estimate of 1.80 — a miss of 405.0%.

Key statistics

Market cap
₹2,436 cr
Forward P/E
0.0
P/B
2.92
Book value
₹128.44
EPS (TTM)
₹-1.15
52-week high
₹647.00
52-week low
₹292.40
50-day MA
₹439.37
200-day MA
₹401.67
Beta
0.14

Analyst view

with an average price target of ₹69.00.

Shareholding

Promoters
72.65%
Institutions
0.13%

Recent filings & reports

DocumentDate
Quarterly results · Q1 FY27
PANACEA BIOTEC LIMITED - Q1 FY2026-27 SUMMARY HEADLINE NUMBERS • Standalone Revenue (Q1): ₹13,471 lakh, up 20.8% vs ₹11,112 lakh in Q4 FY2025-26 • C
2026-08-13
Quarterly results · Q4 FY26
PANACEA BIOTEC LIMITED – FINANCIAL SUMMARY FY 2025-26 (Year Ended March 31, 2026) --- HEADLINE NUMBERS • Total Income from Operations (Consolidated
2026-05-30
Quarterly results · Q3 FY26
PANACEA BIOTEC LIMITED – FINANCIAL SUMMARY Q3 & 9M FY2025-26 Results (December 31, 2025) --- HEADLINE NUMBERS • 9-Month Revenue (Consolidated): ₹47
2026-02-11
Quarterly results · Q2 FY26
PANACEA BIOTEC LIMITED – FINANCIAL SUMMARY (H1 FY2025-26) HEADLINE NUMBERS • Consolidated Revenue from Operations (H1): ₹30,783 lakh vs ₹26,307 lakh
2025-11-14
Annual report FY2025
PANACEA BIOTEC LIMITED – DOCUMENT SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • 41st Annual General Meeting scheduled for Tuesday, September 30, 2
2025-09-08
Quarterly results · Q1 FY26
PANACEA BIOTEC LTD – Q1 FY2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Standalone Q1 FY2026 Revenue from Operations: ₹11,225 lakh (vs ₹5,688 lakh in Q1
2025-08-14
Quarterly results2025-02-14
Quarterly results2024-11-13

Readable in the app.

Deals & corporate news

AnnouncementDate
Received new orders/contracts
Panacea Biotec Limited has informed the Exchange about Bagging/Receiving of orders/contracts
2026-08-05
Receives order for Td vaccine supply worth INR 20.79 crore
Panacea Biotec Limited has received a major government contract worth INR 20.79 crore from the Central Medical Services Society (CMSS), which operates under India's Ministry of Health and Fa
2026-04-11
Bagging/receiving of orders/contracts
Panacea Biotec Limited has informed the Exchange about Bagging/Receiving of orders/contracts
2025-12-24
Company received new orders or contracts
Panacea Biotec Limited has informed the Exchange about Bagging/Receiving of orders/contracts
2025-11-11
Bagging/Receiving of orders/contracts
Panacea Biotec Limited has informed the Exchange about Bagging/Receiving of orders/contracts
2025-10-09

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Panacea Biotec Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.